WallStSmart

Koss Corporation (KOSS)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 1819% more annual revenue ($258.90M vs $13.49M). KOSS leads profitability with a -1.6% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 43/100 (D).

KOSS

Hold

42

out of 100

Grade: D

Growth: 6.7Profit: 2.0Value: 5.0Quality: 5.0

ZEPP

Hold

43

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KOSS3 strengths · Avg: 8.7/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
27.1%8/10

Revenue surging 27.1% year-over-year

EPS GrowthGrowth
37.1%8/10

Earnings expanding 37.1% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

KOSS4 concerns · Avg: 2.0/10
Market CapQuality
$45.39M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-0.7%2/10

ROE of -0.7% — below average capital efficiency

Free Cash FlowQuality
$-1.07M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-1.6%1/10

Currently unprofitable

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$216.30M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : KOSS

The strongest argument for KOSS centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 27.1% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : KOSS

The primary concerns for KOSS are Market Cap, Return on Equity, Free Cash Flow.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

KOSS profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.59 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor CONSUMER ELECTRONICS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (43/100 vs 42/100) and 43.0% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Koss Corporation

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Koss Corporation designs, manufactures, and sells stereo headphones and related accessories in the United States, the Czech Republic, Sweden, Canada, the Russian Federation, Australia, Malaysia, and internationally. The company is headquartered in Milwaukee, Wisconsin.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?